Gene Silencing Flashcards

1
Q

What is RNAi technology?

A

RNA interference (RNAi) is an accurate and potent silencing method

RNA is silenced via degradation or stopping translation by specific double strand RNA sequences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some types of RNAi technologies?

A
  • Small interfering RNAs (siRNAs)
  • MicroRNAs (miRNAs)
  • shRNA
  • CRISPR
  • Others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the key enzyme involved in RNAi technology?

A

DICER breaks down long sequences of dsRNA into smaller fragments (siRNAs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where is the dsRNA sourced for RNAi?

A

Hairpin, complementary RNAs, RNA dependent RNA polymerases

This dsRNA is processed by DICER enzyme into smaller dsRNA fragments known as siRNA (21-23 nucleotides long with 3’ two-nucleotide overhangs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of siRNA in RNAi?

A

siRNA interacts with dicer and activates the RISC (RNA-indicing silencing complex)

see slide 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the role of RISC in RNAi?

A

The AGO2 component of RISC cleaves the passenger strand (sense strand) while the guide strand remains associated with the RISC

The guide strand guides the active RISC to its target mRNA for cleavage by AGO2 component of RISC

see slide 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is miRNA?

A

miRNA is a class of small RNA molecules that negatively regulate gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can miRNA contribute to gene silencing?

A

miRNA gene is transcribed to create primary miRNA

Primary miRNA is cleaved by Drosha (protein complex) to form precursor miRNA

Precursor miRNA is further processed by dicer

This sequence of processed pre-miRNA then interacts with RISC and looses passenger strand while guide strand is retained

The RISC-guide strand complex (miRISC) will bind to complementary (usually only partially complementary) mRNA strand and prevent translation of that sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Do miRISCs have a specific target?

A

No, unlike siRNA-mRNA recognition, miRNA-mRNA recognition does not require perfect pairing, one miRNA can recognize an array of mRNAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Review slide 19

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Are free RNA molecules relatively resistant to decompostion?

A

No, abundant serum nucleases contribute to short half-life in vivo

This instability is resolved through chemical modification of RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the issues for RNA delivery into the cell (site of action)?

A

Their intrinsic properties, including hydrophillic nature, negative charge, and high molecular weight , render them poorly permeable across biological membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the role of a delivery system in siRNA or miRNA therapeutic agents?

A

Facilitating the cellular uptake of siRNA or miRNA to their target sites

Protect the nucleic acids from premature nuclease degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some characteristics of viral vectors as RNA delivery systems?

A
  • Lentiviruses, adenoviruses, and adeno-associated viruses can transfer RNA into the nucleus effectively (high transduction efficiency)
  • Viral vectors have their virulence removed
  • Long-term expression can be achieved by using viruses that integrate into the host genomes (ensure important genes are not unintentionally silenced)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some limitations associated with viral RNA delivery systems?

A
  • Serious safety concerns (high immunogenicity)
  • Risk of insertional mutagenesis
  • High production costs
  • Non-viral vectors are available (better safety profile and lower cost)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the main types of non-viral vectors used in RNA delivery systems?

A
  • Polymer-based
  • Lipid-based
17
Q

What are the advantages of non-viral RNA delivery systems?

A

Good safety profile and low production cost

  • Easily modified to improve their delivery efficiency to acheive site-specific delivery by incorporating targeting ligands
  • Circulation time is enhanced by PEGylation
18
Q

Review slide 26

A
19
Q

What is CRISPR-Cas 9?

A

Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9

It is a genome editing technique:
- Targets a specific section of DNA (RNA fragment binds to complementary DNA sequence)
- Makes a precise cut/break at the target site (and does one of the following: makes a gene nonfunctional, replace allele, or base editing)

see slide 31

20
Q

What is the role of CRISPR arrays?

A

Allow the bacteria to remember the viruses and build a library of RNA sequences to target the viruses DNA

Helps build viral immunity

21
Q

What is the role of Cas9 in normal patient conditions?

A

The enzyme or similar enzymes cut viral DNA apart, which disables the virus

22
Q

Which mutated gene causes sickle cell disease?

A

A point mutation on the hemoglobin-beta gene found on chromosome 11

23
Q

What is the impact of the point mutation on the hemoglobin-beta protein structure or function that causes complications associated with sickle cell?

A

The mutation causes the formation of a protrusion from beta-2 subunit, which binds to a hydrophobic pocket on beta-1

beta-1 and beta-2 subunits polymerize and form long filaments (cause sickling of cells)

see slide 34

24
Q

How is CRISPR-Cas9 therapy used to treat sickle cell disease?

A

Use CRISPR-Cas9 to eliminate BCL11A genes (represses formation of fetal hemoglobin in adult patients)

Now the patient has fetal hemoglobin in addition to the mutated adult hemoglobin, but they will see improvement in condition

see slide 35 and 36

25
Q
A